טוען...
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection
BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) number of death cases is still increasing. One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients...
שמור ב:
| הוצא לאור ב: | Diabetes Metab Syndr |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448951/ https://ncbi.nlm.nih.gov/pubmed/32882643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dsx.2020.08.023 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|